Takeda Qdenga dengue vaccine to be distributed in India by Dr Reddy’s in 2027
Takeda said it will bring Qdenga to India via an exclusive distribution agreement with Dr Reddy’s, expected in the first half of 2027.
Japan-headquartered Takeda Pharmaceutical Company will bring its dengue vaccine Qdenga to India under an exclusive distribution agreement with Dr Reddy’s Laboratories Ltd. The vaccine is the country’s first approved dengue vaccine and is expected to be available in the first half of 2027, the company said.